Michael Exton - Jul 8, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael Exton, Ph.D.
Stock symbol
LXRX
Transactions as of
Jul 8, 2024
Transactions value $
$0
Form type
4
Date filed
7/8/2024, 05:27 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +1.68M $0.00 1.68M Jul 8, 2024 Common Stock 1.68M $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.